Atmos Energy Corporation vs Eli Lilly And Co — how do they compare? Atmos Energy Corporation trades at $169.2 (market cap $28.59B), while Eli Lilly And Co trades at $1,209 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 37.8× Atmos Energy Corporation's market cap, and Atmos Energy Corporation pays the higher dividend (2.36%). Which is the better fit depends on your goals.
| ATO | LLY | |
|---|---|---|
Market Cap | $28.59B | $1.08T |
Sector | Utilities | Health |
52-Week High | $192.25 | $1.24K |
52-Week Low | $162.44 | $639.43 |
Enterprise Value | $38.40B | $1.13T |
Dividend Yield | 2.36% | 0.57% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.
Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.
Trailing returns across standard periods
Latest headlines on both assets
Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →